FDA approves West Conshohocken firm’s drug for liver disease that soared amid obesity epidemic
The drug Rezdiffra, from Madrigal Pharmaceuticals, can reduce scarring and inflammation in people with fatty accumulations in their livers.
The FDA approved a new liver disease drug on Thursday called Rezdiffra, made by West Conshohocken-based Madrigal Pharmaceuticals.Read moreMadrigal Pharmaceuticals
